Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J J Body

Showing results (1-10 of 213) with videos related to

Pageof 22
Sort By:
Bone|May 15, 2002
Calcitonin for the long-term prevention and treatment of postmenopausal osteoporosisJ-J Body
Clinical Rheumatology|September 1, 1995
Calcitonin for prevention and treatment of postmenopausal osteoporosisJ J Body
The Canadian Journal of Oncology|December 1, 1995
Clinical trials in metastatic breast cancer to bone: past--present--futureJ J Body
European Journal of Cancer & Clinical Oncology|July 1, 1984
Cancer hypercalcemia: recent advances in understanding and treatmentJ J Body
Annals of Oncology : Official Journal of the European Society for Medical Oncology|August 1, 1996
Low-dose prednisone and increased risk of development of bone metastasesJ J Body
Hormone Research|January 1, 1993
Calcitonin: from the determination of circulating levels in various physiological and pathological conditions to the demonstration of lymphocyte receptorsJ J Body
Revue Medicale De Bruxelles|October 28, 2008
[Update on treatment of postmenopausal osteoporosis]J J Body
Revue Medicale De Bruxelles|November 1, 1988
[Paraneoplastic hypercalcemia]J J Body
Acta Clinica Belgica|January 1, 1992
Calcitonin: what is new in 1992?J J Body
Cancer|November 15, 1997
Clinical research update: zoledronateJ J Body
Pageof 22

Showing results (1-10 of 213) with videos related to

Sort By:
Pageof 22
Bone|May 15, 2002
Calcitonin for the long-term prevention and treatment of postmenopausal osteoporosisJ-J Body
Clinical Rheumatology|September 1, 1995
Calcitonin for prevention and treatment of postmenopausal osteoporosisJ J Body
The Canadian Journal of Oncology|December 1, 1995
Clinical trials in metastatic breast cancer to bone: past--present--futureJ J Body
European Journal of Cancer & Clinical Oncology|July 1, 1984
Cancer hypercalcemia: recent advances in understanding and treatmentJ J Body
Annals of Oncology : Official Journal of the European Society for Medical Oncology|August 1, 1996
Low-dose prednisone and increased risk of development of bone metastasesJ J Body
Hormone Research|January 1, 1993
Calcitonin: from the determination of circulating levels in various physiological and pathological conditions to the demonstration of lymphocyte receptorsJ J Body
Revue Medicale De Bruxelles|October 28, 2008
[Update on treatment of postmenopausal osteoporosis]J J Body
Revue Medicale De Bruxelles|November 1, 1988
[Paraneoplastic hypercalcemia]J J Body
Acta Clinica Belgica|January 1, 1992
Calcitonin: what is new in 1992?J J Body
Cancer|November 15, 1997
Clinical research update: zoledronateJ J Body
Pageof 22